Soleno Therapeutics Inc. diskutieren
Soleno Therapeutics Inc.
WKN: A3DS0P / Symbol: SLNO / Name: Soleno Therapeutics / Aktie / Micro Cap /
34,08 €
-1,39 %
Soleno Therapeutics (NASDAQ:SLNO) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $123.00 price target on the stock.
Ratings data for SLNO provided by MarketBeat
Soleno Therapeutics (NASDAQ:SLNO) had its "buy" rating reaffirmed by analysts at Guggenheim. They now have a $106.00 price target on the stock.
Ratings data for SLNO provided by MarketBeat
Soleno Therapeutics (NASDAQ:SLNO) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.
Ratings data for SLNO provided by MarketBeat
Soleno Therapeutics (NASDAQ:SLNO) was given a new $125.00 price target on by analysts at The Goldman Sachs Group, Inc.. They now have a "buy" rating on the stock.
Ratings data for SLNO provided by MarketBeat
Soleno Therapeutics (NASDAQ:SLNO) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $75.00 price target on the stock.
Ratings data for SLNO provided by MarketBeat
Soleno Therapeutics (NASDAQ:SLNO) had its "outperform" rating reaffirmed by analysts at Wolfe Research.
Ratings data for SLNO provided by MarketBeat
Soleno Therapeutics (SLNO) had its price target lowered by TD Cowen from $120.00 to $85.00. They now have a "buy" rating on the stock.
Ratings data for SLNO provided by MarketBeat
Soleno Therapeutics (SLNO) had its price target lowered by Wells Fargo & Company from $114.00 to $110.00. They now have an "overweight" rating on the stock.
Ratings data for SLNO provided by MarketBeat
Neueste Beiträge
Evercore_Inc_ in Frontline Ltd. diskutieren, Frontline plc